SARS-CoV-2 vaccination creates strong, persistent T-cell response

L to R) Mikhail Pogorelyy, Ph.D., Paul Thomas, Ph.D., and Anastasia Minervina, Ph.D., all with the St. Jude Department of Immunology Scientists have

Related Keywords

Australia ,Monash ,South Australia ,Crawford ,Queensland ,Melbourne ,Victoria ,Dallas ,Texas ,United States ,Australian ,Paul Thomas ,Jackson Turner ,Walid Awad ,Elisa Rosati ,Teresa Suessen ,Ali Ellebedy ,Ashley Castellaw ,Elizaveta Kalaidina ,William Middleton ,Jamie Rossjohn ,Valerie Cortez ,Rachel Presti ,Anastasia Minervina ,Resha Bajracharya ,Taylor Wilson ,Mikhail Pogorelyy ,Andrea Sant ,Jane Ohalloran ,Ashleigh Gowen ,Robert Mettleman ,David Brice ,Pameal Freiden ,Philip Mudd ,Jan Peterson ,Chun Yang Lin ,Rehana Hakim ,Aisha Souquette ,Brandi Clark ,Stacey Schultz ,Katherine Kedzierska ,Allison Kirk ,Katherine Richards ,Wooseob Kim ,Diego Hijano ,Kim Allison ,Randall Hayden ,Sharlene Teefey ,Yalem Haile ,Nicholas Wohlgemuth ,Motomi Mori ,Maureen Mcgargill ,Kendall Whitt ,R Mikhail Pogorelyy ,Michael Klebert ,Louise Rowntree ,Li Tang ,Elaine Tuomanen ,James Hoffman ,Thomas Fabrizio ,Aaron Schmitz ,Ericka Kirkpatrick Roubidoux ,National Institute For Allergy ,Influenza Vaccine Research For High ,Monash University ,Jude Children Research Hospital ,National Institutes Of Health ,University Of Rochester Medical Center ,Washington University School Of Medicine ,Washington University ,Jude Center ,Australian Research Council Laureate Fellowship ,University Of Melbourne ,Washington University In St ,Jude Department Of Immunology ,Christian Albrecht University Of Kiel ,Influenza Research ,Jude Children ,Research Hospital ,Washington University School ,Jude Tracking ,Host Factors Associated ,Jude Department ,Tingting Lei ,Janeo Halloran ,Christian Albrecht University ,Rochester Medical Center ,Jeremy Chase Crawford ,Jeremie Estepp ,Stacey Schultz Cherry ,Aditya Gaur ,Richard Webby ,Lee Ann Van De Velde ,Ronald Dallas ,Sean Cherry ,National Institutes ,Investigator Fellowship ,Leadership Level ,Influenza Vaccine Research ,High Risk Populations ,National Institute ,Infectious Diseases ,